Guselkumab effectiveness and survival in patients with psoriasis and psoriatic arthritis: Multicenter analysis in daily clinical practice by the Spanish Psoriasis Group

Overview of attention for article published in Dermatologic Therapy, October 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

blogs: 1 blog
twitter: 3 tweeters

facebook: 1 Facebook page

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 6 Mendeley

Summary Blogs Twitter Facebook Dimensions citations

So far, Altmetric has seen 7 tweets from 3 users, with an upper bound of 9,533 followers.

#PublicaSalutIB Efectivitat del guselkumab i supervivència en pacients amb psoriasi i artritis psoriàsica https://t.co/X5lcmrLswk @asef_ibsalut https://t.co/CoRapsPy9n https://t.co/jaCQyM2LJX

Reply Retweet Favourite

#PublicaSalutIB Efectivitat del Guselkumab i supervivència en pacients amb psoriasi i psoriasi artrítica https://t.co/NoWVSskh5s @HManacor @asef_ibsalut https://t.co/FKImtL43Zu https://t.co/YA1VOJq84k

Reply Retweet Favourite

#PublicaSalutIB Efectividad del guselkumab y supervivencia en pacientes con psoriasis y artritis psoriática https://t.co/SYfD8cJP5w @asef_ibsalut https://t.co/JtL4bxrI2e https://t.co/yCQYFORGH5

Reply Retweet Favourite

#PublicaSalutIB Efectivitat del guselkumab i supervivència en pacients amb psoriasi i artritis psoriàsica https://t.co/uhGdRpA8bz @asef_ibsalut https://t.co/t0b1s2S8rK https://t.co/4hJLjjvSTA

Reply Retweet Favourite

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 3 additional tweets.